To test whether endogenous RNase L restricts L1 retrotransposition, we used siRNA-based experiments to deplete RNase L in a human ovarian cancer cell line, Hey1b (Supplementary Figure S2). The gene discussed is RNASEL; the disease is ovarian cancer.